Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis (Nature Cardiovascular Research, (2023), 2, 6, (550-571), 10.1038/s44161-023-00278-y)

Letizia Amadori, Claudia Calcagno, Dawn M. Fernandez, Simon Koplev, Nicolas Fernandez, Ravneet Kaur, Pauline Mury, Nayaab S. Khan, Swathy Sajja, Roza Shamailova, Yannick Cyr, Minji Jeon, Christopher A. Hill, Peik Sean Chong, Sonum Naidu, Ken Sakurai, Adam Ali Ghotbi, Raphael Soler, Natalia Eberhardt, Adeeb RahmanPeter Faries, Kathryn J. Moore, Zahi A. Fayad, Avi Ma’ayan, Chiara Giannarelli

Research output: Contribution to journalComment/debate

Abstract

Correction to: Nature Cardiovascular Research. Published online 8 June 2023. In the version of this article initially published, a protein (pMAPKAPK2) was misspelled in Fig. 1 and Extended Data Fig. 7; a colored box for “AKT” was missing from the second column of regulators in Fig. 5a; Extended Data Fig. 2f was missing a header above the color key; and typographical errors (extraneous citations to refs. 1, 3 and 5) were present in the “Analysis of RNA-seq data from saracatinib-treated tissue” section of Methods. In addition, the Reporting Summary and the legends for Supplementary Figs. 5 and 8 were outdated versions. The errors have been corrected in the HTML and PDF versions of the article.

Original languageEnglish
Pages (from-to)793
Number of pages1
JournalNature Cardiovascular Research
Volume2
Issue number8
DOIs
StatePublished - Aug 2023

Fingerprint

Dive into the research topics of 'Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis (Nature Cardiovascular Research, (2023), 2, 6, (550-571), 10.1038/s44161-023-00278-y)'. Together they form a unique fingerprint.

Cite this